Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125431794 | 12543179 | 4 | F | 20160630 | 20160831 | 20160711 | 20160905 | EXP | JP-ROCHE-1791397 | ROCHE | 73.20 | YR | M | Y | 53.00000 | KG | 20160905 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125431794 | 12543179 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous drip | THE FRACTIONATION DOSE FREQUENCY IS UNCERTAIN. ?DOSE INTERVAL UNCERTAINTY | Y | 125085 | 844 | MG | SOLUTION FOR INFUSION | ||||||
| 125431794 | 12543179 | 2 | SS | Erlotinib | ERLOTINIB | 1 | Oral | 53728 | 150 | MG | TABLET | QD | |||||||
| 125431794 | 12543179 | 3 | C | ZYLORIC | ALLOPURINOL | 1 | Oral | THE FRACTIONATION DOSE FREQUENCY IS UNCERTAIN. ?DOSE INTERVAL UNCERTAINTY | 0 | 100 | MG | TABLET | |||||||
| 125431794 | 12543179 | 4 | C | FAMOTIDINE. | FAMOTIDINE | 1 | Oral | THE FRACTIONATION DOSE FREQUENCY IS UNCERTAIN. ?DOSE INTERVAL UNCERTAINTY | 0 | 20 | MG | TABLET | |||||||
| 125431794 | 12543179 | 5 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | THE FRACTIONATION DOSE FREQUENCY IS UNCERTAIN. ?DOSE INTERVAL UNCERTAINTY | 0 | 10 | MG | TABLET | |||||||
| 125431794 | 12543179 | 6 | C | ENALAPRIL MALEATE. | ENALAPRIL MALEATE | 1 | Oral | THE FRACTIONATION DOSE FREQUENCY IS UNCERTAIN. ?DOSE INTERVAL UNCERTAINTY | 0 | 5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125431794 | 12543179 | 1 | Non-small cell lung cancer |
| 125431794 | 12543179 | 2 | Non-small cell lung cancer |
| 125431794 | 12543179 | 3 | Hyperuricaemia |
| 125431794 | 12543179 | 4 | Gastrooesophageal reflux disease |
| 125431794 | 12543179 | 5 | Hypertension |
| 125431794 | 12543179 | 6 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125431794 | 12543179 | HO |
| 125431794 | 12543179 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125431794 | 12543179 | Alanine aminotransferase increased | |
| 125431794 | 12543179 | Aspartate aminotransferase increased | |
| 125431794 | 12543179 | Blood creatinine increased | |
| 125431794 | 12543179 | Disseminated intravascular coagulation | |
| 125431794 | 12543179 | Enterocolitis | |
| 125431794 | 12543179 | Klebsiella sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125431794 | 12543179 | 1 | 20160427 | 20160609 | 0 | |
| 125431794 | 12543179 | 2 | 20160427 | 20160630 | 0 | |
| 125431794 | 12543179 | 3 | 20160702 | 0 | ||
| 125431794 | 12543179 | 4 | 20160702 | 0 | ||
| 125431794 | 12543179 | 5 | 20160702 | 0 | ||
| 125431794 | 12543179 | 6 | 20160702 | 0 |